Carcinoma of the penis pathophysiology: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
m Robot: Automated text replacement (-mgibson@perfuse.org +charlesmichaelgibson@gmail.com & -kfeeney@perfuse.org +kfeeney@elon.edu) |
||
| Line 2: | Line 2: | ||
{{Carcinoma of the penis}} | {{Carcinoma of the penis}} | ||
'''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto: | '''Editor(s)-in-Chief:''' [[C. Michael Gibson, M.S., M.D.]] [mailto:charlesmichaelgibson@gmail.com] Phone:617-632-7753; Joel Gelman, M.D. [mailto:jgelman@uci.edu], ''Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine'' | ||
==Overview== | ==Overview== | ||
Revision as of 14:16, 1 November 2012
|
Carcinoma of the penis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Carcinoma of the penis pathophysiology On the Web |
|
American Roentgen Ray Society Images of Carcinoma of the penis pathophysiology |
|
Risk calculators and risk factors for Carcinoma of the penis pathophysiology |
Editor(s)-in-Chief: C. Michael Gibson, M.S., M.D. [1] Phone:617-632-7753; Joel Gelman, M.D. [2], Director of the Center for Reconstructive Urology and Associate Clinical Professor in the Department of Urology at the University of California,Irvine
Overview
Pathophysiology
Pathology
- A. Precancerous Dermatologic Lesions
- B. Carcinoma in Situ (Bowen Disease, Erythroplasia of Queyrat)
- C. Invasive Carcinoma of the Penis